-

05:10:08 AM

SEOVF Stock News

SEOVF - Sernova Corp.

12/06/22 7:00 AM

OTC : SEOVF

Sernova Corp. Announces CEO Succession Plan and Expanded Management Team

Sernova Corp. (Sernova) (TSX:SVA) (OTCQB:SEOVF) (FSE/XETRA:PSH), a clinical-stage

RHEA-AI

very positive

11/17/22 7:30 AM

OTC : SEOVF

clinical trial

Sernova Announces First Two Patients Implanted with Cell Pouch™ in the Second Cohort of its US Phase 1/2 Clinical Trial for Type 1 Diabetes

Company’s recent recruitment strategy change has resulted in an unprecedented level of inquiries regarding potential study participation Transplantation of islets into the enhanced 10-channel Cell Pouch is anticipated in early 2023 Company continues to anticipate first interim safety/efficacy data

RHEA-AI

neutral

11/04/22 7:30 AM

OTC : SEOVF

conferences

Sernova to Participate in the Stifel Healthcare Conference

Sernova Corp. (TSX:SVA) (OTCQB:SEOVF) (FSE/XETRA:PSH), a clinical-stage company and leader in cell therapeutics, today announced it will be presenting at the upcoming Stifel Healthcare Conference being held in-person in New York, NY on November

RHEA-AI

neutral

11/03/22 7:30 AM

OTC : SEOVF

clinical trial

Sernova Receives Authorization to Enroll Second Patient Cohort of Phase 1/2 Trial with Cell Pouch System™ for Type 1 Diabetes

Sernova plans to begin enrollment of second cohort in the coming weeks and implant multiple patients with the enhanced capacity 10-channel Cell Pouch before the end of 2022 Positive interim results from patients in the first cohort informed the islet dose and density threshold optimizations for the

RHEA-AI

positive

09/28/22 7:30 AM

OTC : SEOVF

conferences

Sernova to Participate in the Roth Inaugural Healthcare Opportunities Conference

Sernova Corp. (TSX:SVA) (OTCQB:SEOVF) (FSE/XETRA:PSH), a clinical-stage company and leader in regenerative cell therapeutics, today announced it will be presenting at the upcoming Roth Inaugural Healthcare Opportunities Conference being held

RHEA-AI

neutral

09/22/22 7:30 AM

OTC : SEOVF

Sernova Announces Full Exercise of Share Purchase Warrants Expiring September 22, 2022

Sernova Corp. (TSX:SVA) (OTCQB:SEOVF) (FSE / XETRA:PSH), a clinical-stage company and leader in regenerative cell therapeutics, today announced that all remaining share

RHEA-AI

neutral

09/08/22 7:30 AM

OTC : SEOVF

conferences

Sernova to Present at H.C. Wainwright Annual Global Investment Conference and LifeSci Partners HealthTech Symposium

Sernova Corp. (TSX:SVA) (OTCQB:SEOVF) (FSE/XETRA:PSH), a clinical-stage company and leader in regenerative medicine cell therapeutics, today announced it will be presenting at the upcoming H.C. Wainwright 24 th Annual Global Investment

RHEA-AI

neutral

09/07/22 7:30 AM

OTC : SEOVF

management

Sernova Announces the Appointment of Daniel Mahony, Ph.D. to its Board of Directors

Sernova Corp. (TSX:SVA) (OTCQB:SEOVF) (FSE/XETRA:PSH), a clinical-stage company and leader in regenerative medicine cell therapeutics, today

RHEA-AI

neutral

09/01/22 7:33 AM

OTC : SEOVF

Sernova Receives Second Tranche Equity Investment from Evotec of $6.8 Million at a Price of $2.50 Per Share

Sernova Corp. (TSX:SVA) (OTCQB:SEOVF) (FSE/ XETRA:PSH), a clinical-stage company and leader in regenerative medicine cell therapeutics, today announced that it has completed the second and final tranche of its previously announced private

RHEA-AI

neutral

08/30/22 7:00 AM

OTC : SEOVF

conferences

Sernova to Participate in Live Investor Event Hosted by Leede Jones Gable, Inc.

Sernova Corp. (TSX:SVA) (OTCQB:SEOVF) (FSE/XETRA:PSH), a clinical-stage company and leader in regenerative medicine cell therapeutics, today announced that Dr. Philip Toleikis,

RHEA-AI

neutral